Atlas Trials

Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)

Clinical trial NCT01770301 · COMPLETED

Trial details

NCT number
NCT01770301
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Sex-cord Stromal Tumor
Start date
2013-02-01
Primary completion
2017-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.